Basilea Pharmaceutic...
SWX:BSLN
CHF 51,70
+ CHF0,50 (0,98%)
51,70 CHF
+CHF0,50 (0,98%)
End-of-day quote: 03/25/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

G
66,74%
5-year Growth Rate
R
5/6
5-year Risk Analysis
O
15,54%
Outlook 12/26
W
5,86%
Margin of safety
T
68,28%
Analyst Price Target
H
UP
50-week EMA Trend

Company Info

EPS Growth 5Y
25,28%
Revenue growth 5Y
10,16%
Price growth 5Y
9,53%
Market Cap
CHF0,64 B
Long-Term Debt
CHF0,10 B
Quarterly earnings
08/19/2026 (E)
Dividend
CHF0,00
Dividend Yield
0,00%
Industry
ISIN Number

Basilea Pharmaceutica Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

CHF87,00
68.28%
68.28
Last Update: 03/26/2026
Analysts: 6

Highest Price Target CHF120,00

Average Price Target CHF87,00

Lowest Price Target CHF59,40

Top growth stocks in the health care sector

Stock Rate of Return 5Y Price 5Y Div. 5Y G R O W T H
Basilea Pharmaceutica
SWX:BSLN
9,53% 9,53% 0,00% 66,74% 5/6 15,54% 5,86% 68,28% UP
×